These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19093199)

  • 1. Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia.
    Gellad ZF; Almirall D; Provenzale D; Fisher DA
    Dig Dis Sci; 2009 Nov; 54(11):2497-502. PubMed ID: 19093199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
    Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
    Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
    Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
    Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of fecal occult blood test as a screening method for asymptomatic patients with colon polyps].
    Lee SH; Lee KS; Lee JY; Ji JH; Park JK; Park YS; Hwang JH; Kim JW; Jung SH; Kim N; Lee DH; Kim SG; Kim JS; Jung HC; Song IS
    Korean J Gastroenterol; 2006 Dec; 48(6):388-94. PubMed ID: 17189921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study.
    Partin MR; Burgess DJ; Burgess JF; Gravely A; Haggstrom D; Lillie SE; Nugent S; Powell AA; Shaukat A; Walter LC; Nelson DB
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):422-34. PubMed ID: 25471345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes.
    Ting PH; Lin XH; Jiang JK; Luo JC; Chen PH; Wang YP; Hsin IF; Perng CL; Hou MC; Lee FY
    J Chin Med Assoc; 2018 Sep; 81(9):759-765. PubMed ID: 29778550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
    Vijan S; Hwang EW; Hofer TP; Hayward RA
    Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study).
    Fernández-Bañares F; Clèries R; Boadas J; Ribes J; Oliva JC; Alsius A; Sanz X; Martínez-Bauer E; Galter S; Pujals M; Pujol M; Del Pozo P; Campo R
    BMC Cancer; 2019 Jul; 19(1):734. PubMed ID: 31345180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative immunochemical fecal occult blood test for colorectal neoplasia.
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an immunochemical test for faecal occult blood in screening for colorectal neoplasia in a high risk group.
    Williams JA; Hunter R; Thomas DW; Coles ME; Leong AS; Walsh R; Hoffmann DC; Huber TW; Sen A
    Aust N Z J Surg; 1987 Dec; 57(12):951-7. PubMed ID: 3439939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test.
    Botteri E; Crosta C; Bagnardi V; Tamayo D; Sonzogni AM; De Roberto G; de Leone A; Lowenfels A; Maisonneuve P
    Dig Liver Dis; 2016 Mar; 48(3):321-6. PubMed ID: 26739617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history.
    Rex DK; Lehman GA; Ulbright TM; Smith JJ; Pound DC; Hawes RH; Helper DJ; Wiersema MJ; Langefeld CD; Li W
    Am J Gastroenterol; 1993 Jun; 88(6):825-31. PubMed ID: 8503374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.